FDA Advisory Panel Unanimously Recommends Approval of the STAN Fetal heart monitor from Neoventa Medical

Gaithersburg, Maryland, June 23 2005

The U.S. Food and Drug Administration’s (FDA) Obstetrics and Gynecology Advisory Panel voted Thursday to recommend approval of the STAN® S31 Fetal heart monitor Pre-Market Approval (PMA) application. STAN helps clinicians identify babies at risk due to oxygen deficiency during labor. It also reduces the number of unnecessary operative interventions.

Read more
Page 3 of 3 123

# #